Discover
AVNS
Avanos Medical, Inc.
24.63
5700 x undefined
5700 x undefined
bid
ask
-
0.25
1.00%
5700 @ 04:00 PM
24.63 +0.00 (0.00%)
| Ytd | 119.32% | |
| 1y | 96.73% |
24.46
day range
24.92
9.30
52 week range
25.49
| Open | 24.90 | Prev Close | 24.88 | Low | 24.46 | High | 24.92 | Mkt Cap | 1.15B |
| Vol | 2.04M | Avg Vol | 1.62M | EPS | -1.60 | P/E | N/A | Forward P/E | 19.62 |
| Beta | 1.57 | Short Ratio | 1.33 | Inst. Own | 90.60% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-05 | 50-d Avg | 24.81 | 200-d Avg | 15.87 | 1yr Est | 22.50 |
| Income Statement | |||
| Total Revenue | 182.20M | ||
| Revenues (USD) | 182.20M | ||
| Cost of Revenue | 88.00M | ||
| Gross Profit | 94.20M | ||
| Operating Expenses | 82.90M | ||
| Research and Development Expense | 5.20M | ||
| Selling, General and Administrative Expense | 77.70M | ||
| Operating Income | 11.30M | ||
| Interest Expense | 1.50M | ||
| Income Tax Expense | 2.50M | ||
| Net Income | 5.10M | ||
| Net Income Common Stock | 5.10M | ||
| Net Income Common Stock (USD) | 5.10M | ||
| Consolidated Income | 5.10M | ||
| Earnings per Basic Share | 0.11 | ||
| Earnings per Basic Share (USD) | 0.11 | ||
| Earnings per Diluted Share | 0.11 | ||
| Earning Before Interest & Taxes (EBIT) | 9.10M | ||
| Earning Before Interest & Taxes (USD) | 9.10M | ||
| Weighted Average Shares | 46.50M | ||
| Balance Sheet | |||
| Cash and Equivalents | 65.60M | ||
| Cash and Equivalents (USD) | 65.60M | ||
| Trade and Non-Trade Receivables | 103.00M | ||
| Current Assets | 325.00M | ||
| Property, Plant & Equipment Net | 150.50M | ||
| Total Assets | 1.05B | ||
| Debt Current | 21.30M | ||
| Total Debt | 138.40M | ||
| Current Liabilities | 131.20M | ||
| Debt Non-Current | 117.10M | ||
| Total Liabilities | 268.00M | ||
| Accumulated Retained Earnings (Deficit) | -774.80M | ||
| Accumulated Other Comprehensive Income | -36.00M | ||
| Shareholders Equity | 782.10M | ||
| Shareholders Equity (USD) | 782.10M | ||
| Assets Non-Current | 725.10M | ||
| Total Debt (USD) | 138.40M | ||
| Goodwill and Intangible Assets | 508.70M | ||
| Inventory | 141.30M | ||
| Liabilities Non-Current | 136.80M | ||
| Trade and Non-Trade Payables | 52.30M | ||
| Tax Assets | 33.00M | ||
| Tax Liabilities | 5.60M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 10.20M | ||
| Net Cash Flow from Financing | -3.20M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -24.20M | ||
| Capital Expenditure | -4.30M | ||
| Issuance (Purchase) of Equity Shares | -900.00K | ||
| Issuance (Repayment) of Debt Securities | -2.30M | ||
| Net Cash Flow from Investing | -7.70M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -3.40M | ||
| Net Cash Flow from Operations | -12.30M | ||
| Effect of Exchange Rate Changes on Cash | -1000.00K | ||
| Share Based Compensation | 3.70M | ||